Menu

• Ask a Health Expert about BLOOD LACTATE DEHYDROGENASE ABNORMAL
• Post Your Side Effect related to BLOOD LACTATE DEHYDROGENASE ABNORMAL
• BLOOD LACTATE DEHYDROGENASE ABNORMAL and FDA Warnings
• BLOOD LACTATE DEHYDROGENASE ABNORMAL in Patients Wiki
• Report BLOOD LACTATE DEHYDROGENASE ABNORMAL in Drug Side Effect Survey

BLOOD LACTATE DEHYDROGENASE ABNORMAL side effect

What is BLOOD LACTATE DEHYDROGENASE ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prednisolone Side Effects Report #5615727-3
Physician from JAPAN reported PREDNISOLONE problem on Jan 21, 2008. Female patient, 73 years of age, was diagnosed with systemic lupus erythematosus and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase abnormal, disseminated intravascular coagulation, epistaxis, fibrin degradation products increased, haemoglobin decreased, metastases to bone marrow, metastases to lymph nodes, neuroendocrine carcinoma of the skin, prothrombin time prolonged, . PREDNISOLONE dosage: 10-60MG DAILY, ORAL. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient died.

Enbrel Side Effects Report #5554515-3
ENBREL problem was reported by a Health Professional from GERMANY on Nov 29, 2007. Female patient, 26 years of age, was diagnosed with juvenile arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase abnormal, cytomegalovirus infection, gamma-glutamyltransferase increased, pyrexia, turner's syndrome, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5511132-9
Physician from JAPAN reported VELCADE problem on Oct 26, 2007. Female patient, 48 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase abnormal, hepatic function abnormal, . VELCADE dosage: 2.00 MG. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE, SIGMART. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5362768-X
VELCADE problem was reported by a Physician from JAPAN on May 29, 2007. Female patient, 48 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase abnormal, hepatic function abnormal, . VELCADE dosage: 2.00 MG. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE, SIGMART. Patient was hospitalized. Patient recovered.


Valproate Side Effects Report #5645736-X
Consumer or non-health professional from FRANCE reported VALPROATE problem on Feb 19, 2008. Male patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: ammonia increased, blood lactate dehydrogenase abnormal, coagulation time prolonged, depressed level of consciousness, encephalopathy, hepatic failure, liver function test abnormal, vomiting, . VALPROATE dosage: INCREASING REGIMEN, MAXIMUM DAILY DOSE OF 25MG/KG). Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5570216-X
VELCADE problem was reported by a Physician from NETHERLANDS on Dec 05, 2007. Male patient, 63 years of age, weighting 202.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, blood lactate dehydrogenase abnormal, cholelithiasis, constipation, fracture, hyperglycaemia, hypokalaemia, meningioma, necrosis, . VELCADE dosage: 2.70 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, HYDROCHLOROTHIAZIDE, SIMVASTATIN, METFORMIN, GLIMEPIRIDE, VALACYCLOVIR. Patient died on 10/22/2007.

Heparin Side Effects Report #5678679-6
Health Professional from UNITED STATES reported HEPARIN ECTION problem on Mar 14, 2008. Male patient, 50 years of age, weighting 237.0 lb, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood immunoglobulin e abnormal, blood lactate dehydrogenase abnormal, chest discomfort, condition aggravated, dyspnoea, erythema, haemoglobin abnormal, oxygen saturation decreased, . HEPARIN ECTION dosage: unknown. During the same period patient was treated with HEPARIN ECTION. Patient was hospitalized. Patient recovered.

Keppra Side Effects Report #5612069-7
KEPPRA problem was reported by a Consumer or non-health professional from SWEDEN on Jan 11, 2008. Female patient, 57 years of age, was diagnosed with grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood lactate dehydrogenase abnormal, dehydration, delusional disorder, persecutory type, metabolic acidosis, . KEPPRA dosage: unknown. Patient was hospitalized. Patient recovered.

Immune Side Effects Report #5447456-3
Consumer or non-health professional from GERMANY reported IMMUNE GLOBULIN INTRAVENOUS problem on Apr 13, 2007. Male patient, 51 years of age, was diagnosed with paraneoplastic syndrome and was treated with IMMUNE GLOBULIN INTRAVENOUS. After drug was administered, patient experienced the following problems/side effects: back pain, blood bilirubin increased, blood lactate dehydrogenase abnormal, flank pain, haemolysis, hypersensitivity, . IMMUNE GLOBULIN INTRAVENOUS dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, DIGITOXIN, ASPIRIN, SPIRIVA, SEREVENT, NEXIUM. Patient recovered.


Immune Side Effects Report #5464125-4
IMMUNE GLOBULIN INTRAVENOUS problem was reported by a Consumer or non-health professional from GERMANY on Sept 12, 2007. Male patient, 51 years of age, was diagnosed with paraneoplastic syndrome and was treated with IMMUNE GLOBULIN INTRAVENOUS. After drug was administered, patient experienced the following problems/side effects: back pain, blood bilirubin increased, blood lactate dehydrogenase abnormal, flank pain, haemolysis, hypersensitivity, . IMMUNE GLOBULIN INTRAVENOUS dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, DIGITOXIN, ASPIRIN, SPIRIVA, SEREVENT, NEXIUM. Patient recovered.

Kaletra Side Effects Report #5470277-2
Consumer or non-health professional from ISRAEL reported KALETRA problem on Sept 17, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Kaletra Side Effects Report #5397228-3
KALETRA problem was reported by a Consumer or non-health professional from ISRAEL on July 15, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Kaletra Side Effects Report #5397228-3
Consumer or non-health professional from ISRAEL reported KALETRA problem on July 15, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.